BIOMAT Database Logo BIOMAT Database Logo

Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas. 1992

K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis 46202.

Cancer cells have an increased ability to synthesize GTP (guanosine triphosphate) because of increased activity of IMP DH (inosine 5'-phosphate dehydrogenase, EC 1.1.1.205). Because IMP DH activity is rate limiting for de novo biosynthesis of GTP, this enzyme was suggested as a sensitive target for chemotherapy. Tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide) is converted in the cells into the active metabolite, TAD, (thiazole-4-carboxamide adenine dinucleotide) which potently inhibits IMP DH activity. By adding TAD to tissue extracts one can determine the extent of inhibition of IMP DH. We applied the IMP DH assay method to extracts of normal ovaries (N = 11) and epithelial ovarian carcinomas (N = 10). The IMP DH activity (mean +/- SE) in ovarian carcinoma was 21.1 +/- 5.8 which was markedly higher than that observed in normal ovaries (2.9 +/- 0.7 nmol/hr/mg protein) (P < 0.05%). The inhibition by TAD of IMP DH activity in ovarian carcinomas (N = 4) was 81%. The results indicate that IMP DH activity is elevated sevenfold in ovarian carcinomas as compared to normal ovary and can be inhibited by exposure to tiazofurin (TAD). Similar high IMP DH activity and inhibition of the activity by TAD was observed in patients with chronic granulocytic leukemia in blast crisis among whom 70 to 80% remissions were reported. Since there is increased IMP DH activity in human ovarian carcinomas and in OVCAR-5 cells and tiazofurin and TAD inhibit IMP DH activity of these cells and the proliferation of human ovarian carcinoma xenografts in the mouse, tiazofurin may merit serious consideration for a Phase II trial for patients with recurrent/refractory epithelial ovarian carcinoma.

UI MeSH Term Description Entries
D007168 IMP Dehydrogenase An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205. Inosinic Acid Dehydrogenase,Inosine-5-Monophosphate Dehydrogenase,Acid Dehydrogenase, Inosinic,Dehydrogenase, IMP,Dehydrogenase, Inosine-5-Monophosphate,Dehydrogenase, Inosinic Acid,Inosine 5 Monophosphate Dehydrogenase
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D005260 Female Females
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
January 1989, Advances in enzyme regulation,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
January 1989, Leukemia research,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
July 1989, Cancer research,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
[HISTOCHEMICAL EFFECT OF INOSINE-5'-PHOSPHATE-DEHYDROGENASE ACTIVITY].
January 1965, Tsitologiia,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE.
October 1963, The Biochemical journal,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Inosine 5'-phosphate dehydrogenase of pea seeds.
April 1961, The Biochemical journal,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
January 1992, Life sciences,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Inosine 5'-phosphate dehydrogenase activity in normal and leukemic blood cells.
October 1979, Klinische Wochenschrift,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
The conformation of inosine 5'-monophosphate (IMP) bound to IMP dehydrogenase determined by transferred nuclear overhauser effect spectroscopy.
November 1996, The Journal of biological chemistry,
K Y Look, and G P Sutton, and Y Natsumeda, and J N Eble, and F B Stehman, and C E Ehrlich, and E Olah, and N Prajda, and P Bosze, and S Eckhardt
Inosine 5'-phosphate dehydrogenase. Site of inhibition by guanosine 5'-phosphate and of inactivation by 6-chloro- and 6-mercaptopurine ribonucleoside 5'-phosphates.
March 1967, Biochemistry,
Copied contents to your clipboard!